[{"AccountsPayableCurrent_0_Q2_USD":8182000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":1284000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":10535000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":5584000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":148225000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":12.83,"EarningsPerShareDiluted_2_Q2_USD":0.24,"EarningsPerShareDiluted_1_Q2_USD":0.23,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":7093000.0,"RepaymentsOfNotesPayable_2_Q2_USD":12500000.0,"RepaymentsOfLongTermDebt_2_Q2_USD":11500000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":6080000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":394000.0,"LoansPayableCurrent_0_Q2_USD":47069000.0,"PaymentsToAcquireIntangibleAssets_2_Q2_USD":368226000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":993000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-8645000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":34247977.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":623000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":369494000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":29694000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":67218000.0,"EarningsPerShareBasic_1_Q2_USD":0.23,"EarningsPerShareBasic_2_Q2_USD":0.25,"ConvertibleDebtFairValueDisclosures_0_Q2_USD":129151000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":44898000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q2_USD":67181000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":67181000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":67181000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":67181000.0,"OtherAssetsNoncurrent_0_Q2_USD":163000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":34395266.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q2_USD":67180000.0,"InventoryWorkInProcess_0_Q2_USD":2643000.0,"AccruedBonusesCurrent_0_Q2_USD":2331000.0,"AccruedRoyaltiesCurrent_0_Q2_USD":12531000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2_Q2_USD":357000.0,"StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_2_Q2_shares":39411.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":154569000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":78058000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":2547000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":357000.0,"ProceedsFromIssuanceOfSecuredDebt_2_Q2_USD":192117000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":1922000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":8697000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":9084000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":696000.0,"NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_2_Q2_USD":1555000.0,"LongTermLoansPayable_0_Q2_USD":133862000.0,"InvestmentIncomeNet_2_Q2_USD":226000.0,"InvestmentIncomeNet_1_Q2_USD":14000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":33590000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_2_Q2_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":5584000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":3860000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":-21794000.0,"CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_1_Q2_USD":12899000.0,"CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_2_Q2_USD":40128000.0,"CostOfGoodsAndServicesSoldAmortization_1_Q2_USD":16795000.0,"AccruedMarketingCostsCurrent_0_Q2_USD":424000.0,"CostOfGoodsAndServicesSoldAmortization_2_Q2_USD":27090000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_2_Q2_USD":0.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"InventoryRawMaterials_0_Q2_USD":5153000.0,"InventoryFinishedGoods_0_Q2_USD":11019000.0,"IncreaseDecreaseInInventories_2_Q2_USD":9785000.0,"StockholdersEquity_0_Q2_USD":155767000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-351391000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":15156000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":5125000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1662000.0,"NetIncomeLoss_2_Q2_USD":8508000.0,"NetIncomeLoss_1_Q2_USD":8058000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":37185000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-369888000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":310909000.0,"LiabilitiesCurrent_0_Q2_USD":252111000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":646870000.0,"Liabilities_0_Q2_USD":491103000.0,"InventoryNet_0_Q2_USD":18815000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2005000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":8242000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1935000.0,"AccountsReceivableNetCurrent_0_Q2_USD":81195000.0,"AdditionalPaidInCapital_0_Q2_USD":507124000.0,"Assets_0_Q2_USD":646870000.0,"AssetsCurrent_0_Q2_USD":250813000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":145678000.0,"CommonStockSharesIssued_0_Q2_shares":34494302.0,"AccruedLiabilitiesCurrent_0_Q2_USD":25111000.0,"CommonStockSharesOutstanding_0_Q2_shares":34494302.0,"GrossProfit_1_Q2_USD":48364000.0,"GrossProfit_2_Q2_USD":87351000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":8304000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":8754000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":246000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":246000.0,"CommonStockValue_0_Q2_USD":34000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockSharesAuthorized_0_Q2_shares":100000000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":29322000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":60582000.0,"ShareBasedCompensation_2_Q2_USD":10535000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.661,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.013,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":1626000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":5159000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":4454000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":35089740.0,"AmortizationOfIntangibleAssets_1_Q2_USD":16795000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":27090000.0,"CurrentFederalTaxExpenseBenefit_2_Q2_USD":0.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.03,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.028,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":35091906.0,"WarrantsNotSettleableInCashFairValueDisclosure_0_Q2_USD":8043000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":2493000.0,"PreferredStockValue_0_Q2_USD":null,"ConvertibleLongTermNotesPayable_0_Q2_USD":96046000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q2_USD":369494000.0,"InterestExpense_1_Q2_USD":8259000.0,"InterestExpense_2_Q2_USD":13082000.0,"InterestPaidNet_2_Q2_USD":8259000.0,"InterestPayableCurrent_0_Q2_USD":1436000.0,"ProceedsFromConvertibleDebt_2_Q2_USD":138277000.0,"OperatingExpenses_1_Q2_USD":31815000.0,"OperatingIncomeLoss_1_Q2_USD":16549000.0,"OperatingIncomeLoss_2_Q2_USD":21610000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"OperatingExpenses_2_Q2_USD":65741000.0,"WorkersCompensationLiabilityCurrent_0_Q2_USD":1586000.0,"Ticker":"COLL","CIK":"1267565","name":"COLLEGIUM PHARMACEUTICAL, INC","OfficialName":"Collegium Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"619097451.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200805"}]